Show simple item record

dc.contributor.authorNoel, J.M.
dc.contributor.authorJackson, C.W.
dc.date.accessioned2021-02-08T20:13:23Z
dc.date.available2021-02-08T20:13:23Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/10713/14536
dc.description.abstracten_US
dc.description.urihttps://doi.org/10.1093/ajhp/zxaa303en_US
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofAmerican Journal of Health-System Pharmacy
dc.subjectantipsychoticsen_US
dc.subjectschizoaffective disorderen_US
dc.subjectschizophreniaen_US
dc.subjecttherapeutic position statementen_US
dc.titleASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorderen_US
dc.typeArticleen_US
dc.identifier.doi10.1093/ajhp/zxaa303
dc.identifier.pmid32871013


This item appears in the following Collection(s)

Show simple item record